Recursion Pharmaceuticals (RXRX) Debt Ratio (2020 - 2026)
Recursion Pharmaceuticals (RXRX) posted Debt Ratio of 0.01 for Q1 2026, down 2.98% on a QoQ basis from 0.01 in Q4 2025, and down 35.98% year-over-year from 0.02 in Q1 2025.
Recursion Pharmaceuticals (RXRX) Debt Ratio (2020 - 2026) Analysis & Trends
Recursion Pharmaceuticals' Debt Ratio history runs 7 years deep, the most recent figure standing at 0.01 for Q1 2026.
- Quarterly Debt Ratio fell 35.98% year-over-year to 0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01 (down 35.98% YoY) and the FY2025 annual result came in at 0.01, down 33.21% from the prior year.
- Debt Ratio was 0.01 for Q1 2026 at Recursion Pharmaceuticals, down from 0.01 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.04 in Q2 2024 and bottomed at 0.0 in Q4 2022.
- A 5-year average of 0.01 and a median of 0.01 in 2026 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2022 — Debt Ratio tumbled 93.54% — and 2024, when it jumped 2208.58%.
- Recursion Pharmaceuticals' Debt Ratio stood at 0.0 in 2022, then surged by 128.57% to 0.0 in 2023, then jumped by 984.57% to 0.02 in 2024, then plunged by 33.21% to 0.01 in 2025, then dropped by 2.98% to 0.01 in 2026.
- Business Quant data shows RXRX's Debt Ratio at 0.01 in Q1 2026, 0.01 in Q4 2025, and 0.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.59 Bn | 933.22 Mn | -6.02 Mn | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.01 |